• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

DNDi is partnering with Médecins Sans Frontières South Asia for the Without Borders Media Fellowship 2025 

Home > News

DNDi is partnering with Médecins Sans Frontières South Asia for the Without Borders Media Fellowship 2025 

6 Jun 2025

About the fellowship 

Médecins Sans Frontières (MSF) South Asia is calling for proposals by journalists, photographers, filmmakers, and newsrooms editors to apply for the 2025-2026 Without Borders Media Fellowship. The fellowship aims to encourage humanitarian and health-related journalism and reporting through scientific storytelling that draws attention to emerging local and cross-border issues in the South Asia region.  

Journalists accepted for the fellowship are expected to produce at least one in-depth report by engaging with affected populations and stakeholders. The fellows will have an opportunity to work closely with mentors, who are experts and thought leaders in journalism and public health, as well as medical and operations specialists from the MSF movement. 

Stories from the heart of a crisis give a voice to vulnerable people, support medical and humanitarian advocacy, and encourage dialogue on humanitarian values. Fellows will be encouraged to work together, build communities of practice, and support humanitarian actors to better understand crises and contexts, while working with compassion. 

Three grant categories are open for applications: 

1) General grant 

The general grant supports in-depth reporting across five themes: tuberculosis, HIV, health impact of climate change, women’s health, or the impact of caste on health. 

This grant will enable journalists to highlight and investigate a range of transversal health subjects in South Asia through training, insightful storytelling, and extensive field exposure. Successful applicants will receive a grant to cover reporting costs and access to experts to enrich their reporting. 
 

2) MSF-DNDi grant on neglected tropical diseases and gender responsive research and development 

The MSF-DNDi grant focuses on raising awareness and fostering a better understanding of neglected tropical diseases (NTDs), such as dengue, lymphatic filariasis, leishmaniasis, and mycetoma, which affect millions of people in South Asia. These diseases are driven by social and environmental factors including poverty, poor sanitation, lack of adequate treatment, and limited access to healthcare. This grant aims to encourage exploration of the complexities of NTDs through the lens of gender, paediatrics, and climate change. It emphasizes the need for targeted interventions such as safe, affordable, and effective treatment, and improved healthcare infrastructure. 

The grant will also focus on critical issues surrounding gender equity in clinical trials; the intersection of gender, climate, and infectious diseases; the systemic challenges faced by women in health research; and the urgent need for actionable strategies to address disparities. Recipients will receive financial support for reporting expenses and access to DNDi experts to support comprehensive reporting.  

 
3) MSF-GARDP (The Global Antibiotic Research & Development Partnership) grant on antimicrobial resistance  

Antimicrobial resistance (AMR) – also known as antibiotic resistance – is a growing threat worldwide – and already accounts for 4.71 million associated deaths each year, of which 20% are in India. The predominant narrative has explored excessive and inappropriate use of antibiotics as a key contributor to AMR, but lack of access to the right antibiotics is a contributor that has largely been ignored. According to recent findings from the Global Burden of Antimicrobial Resistance study, AMR-related mortality has remained relatively stable in recent decades, but a sharp rise is expected, with AMR-related deaths projected to increase by more than 70% by 2050. The MSF-GARDP grant on AMR aims to explore the theme of access versus excess in the South Asian and lower-middle-income country context, diving  deeper into issues around access to appropriate antibiotics. Recipients will receive financial support for reporting expenses and gain access to GARDP experts to support comprehensive reporting. 

Applications open on 15 May 2025 and close on 15 June 2025. 

READ more about the grant and how to apply

Photo credit: Matt Bouch-DNDi

Asia

Read, watch, share

Loading...
News
5 Jun 2025

Meet the DNDi Eastern Africa 2024-2025 Media Fellows

Press releases
5 Jun 2025

Colombia becomes first country to recommend rapid tests to diagnose Chagas disease

Statements
27 May 2025

DNDi interventions at the 78th World Health Assembly

Press releases
22 May 2025

Six African nations commit to eliminate deadly neglected disease visceral leishmaniasis

Videos
20 May 2025

The Children of the Sierra

Press releases
13 May 2025

First all-oral treatment for a rare but deadly strain of sleeping sickness now available and being used to treat patients in endemic countries in Africa

Statements
8 May 2025

DNDi’s briefing note for 78th World Health Assembly

Marco Krieger
News
30 Apr 2025

Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License